Optima MedycynaS.A.

General medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2007-03-01
Share capital
992 704,00 PLN
Activity description

Optima Medycyna is a company that offers advanced laser treatments using the Fotona Spectro SP technology, focusing on aesthetic medicine, dermatology, gynecology, and surgical procedures. They also provide online registration, e-prescriptions, and teleconsultations for patients. Additionally, they are involved in a grant project to support primary healthcare, funded by the European Regional Development Fund.

Registered address
ul. Niemodlińska 79, 45-864 Opole, Poland
Website
optima-medycyna.euWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-68166-45800-TIRJA-26

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 13.84mMedianUSD 759.34kAverageUSD 2.31m
Net profit
This companyUSD 2.07mMedianUSD 38.62kAverageUSD 164.01k
Operating costs
This companyUSD 11.40mMedianUSD 666.23kAverageUSD 2.09m
Assets
This companyUSD 13.13mMedianUSD 259.35kAverageUSD 1.49m

Bank accounts

Registered as a VAT taxpayer on 1994-12-19. Active

  • Bank spółdzielczy
    Bank spółdzielczy
    59 8905 0000 2001 0021 7082 0002
  • Erste Bank Polska
    76 1090 2226 0000 0001 5013 1025
  • Bank spółdzielczy
    Bank spółdzielczy
    86 8905 0000 2001 0021 7082 0001

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$97,461
Buildings and premises
$848.9K

MSiG notices

Publication dateEvent
Jan 23, 2020Merger plan
Jul 28, 2016Call to creditors

Public aid

132 public aid cases recorded, with a total value of $516,343.

PurposeGross amount
Aid in the form of wage subsidies for employing workers with disabilities
$1,303
Aid in the form of wage subsidies for employing workers with disabilities
$1,459
Aid in the form of wage subsidies for employing workers with disabilities
$1,459

European Funds

ProjectEU co-financing
TERMOMODERNIZACJA BUDYNKU PRZYCHODNI LEKARSKIEJ SPÓŁKI OPTIMA MEDYCYNA
$113.9K
Wzrost wydajności i rozwój usług medycznych świadczonych w zakresie opieki nad dzieckiem poprzez remont i adaptację pomieszczeń w celu uruchomienia poradni pediatrycznej POZ w Optima Medycyna na ul. Dambonia 171 w Opolu
$171.8K

Tenders

No recorded participation in tenders.

National Health Fund (NFZ) contracts

Optima Medycyna has been an NFZ healthcare provider since 2008. In 2026 it is performing 5 contracts with a total value of USD 3.85m. All its contracts were worth USD 32.63m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Ambulatoryjna opieka specjalistycznaopolskie1USD 2.50m
Podstawowa Opieka Zdrowotnaopolskie1USD 903.41k
Opieka psychiatryczna i leczenie uzależnieńopolskie1USD 249.70k
Leczenie stomatologiczneopolskie1USD 104.59k
Świadczenia pielęgnacyjne i opiekuńczeopolskie1USD 94.53k

Trademarks

Optima Medycyna currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2016.

MarkProtected until
Optima MEDYCYNA–
Optima MEDYCYNA–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Adam Szlęzak – President of the Management Board
Dominika Anna Świtała – Management Board Member
Piotr Ernest Jelitto – Vice President of the Management Board
Piotr Gustaw Straub – Attorney-in-fact (sole)

Manner of representation

1. The company is represented by: 1) in the case of a one-person management board, the President of the Management Board; 2) in the case of a two-person management board, each member of the management board independently; 3) in the case of a multi-member management board, each member of the management board independently, subject to property matters and incurring contractual obligations in an amount exceeding PLN 2,000,000.00 on a one-off basis, which require the joint action of two members of the management board or the action of a member of the management board together with a commercial proxy. 2. The rule referred to in point 1 subpoint 3 does not apply to the conclusion and amendment of agreements for the provision of healthcare services with the National Health Fund – the director of the relevant branch, or the legal successor of such entity. In such matters, each member of the management board may act independently, provided that the termination of such an agreement requires the joint action of two members of the management board or the action of a member of the management board together with a commercial proxy.

Supervisory board

Ernest Jelito – Supervisory Board Member
Maria Jadwiga Jelito – Supervisory Board Member
Victoria Kuharev – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
100%
100%
100%

Competitors

Change history

DateEvent
2023-12-12Share capital change
2022-11-10PKD change
2020-04-06Address change
2017-01-19Share capital change
2015-07-14PKD change

FAQ

Last updated: 2026-07-09